Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.
HLA-B*27 exerts protective effects in hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections. While the immunological and virological features of HLA-B*27-mediated protection are not fully understood, there is growing evidence that the presentation of specific immunodominant HLA-B...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c948d12be085467aa0d4b5ccb27562d4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c948d12be085467aa0d4b5ccb27562d4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c948d12be085467aa0d4b5ccb27562d42021-11-18T06:06:19ZRapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.1553-73661553-737410.1371/journal.ppat.1003042https://doaj.org/article/c948d12be085467aa0d4b5ccb27562d42012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23209413/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374HLA-B*27 exerts protective effects in hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections. While the immunological and virological features of HLA-B*27-mediated protection are not fully understood, there is growing evidence that the presentation of specific immunodominant HLA-B*27-restricted CD8+ T-cell epitopes contributes to this phenomenon in both infections. Indeed, protection can be linked to single immunodominant CD8+ T-cell epitopes and functional constraints on escape mutations within these epitopes. To better define the immunological mechanisms underlying HLA-B*27-mediated protection in HCV infection, we analyzed the functional avidity, functional profile, antiviral efficacy and naïve precursor frequency of CD8+ T cells targeting the immunodominant HLA-B*27-restricted HCV-specific epitope as well as its antigen processing and presentation. For comparison, HLA-A*02-restricted HCV-specific epitopes were analyzed. The HLA-B*27-restricted CD8+ T-cell epitope was not superior to epitopes restricted by HLA-A*02 when considering the functional avidity, functional profile, antiviral efficacy or naïve precursor frequency. However, the peptide region containing the HLA-B*27-restricted epitope was degraded extremely fast by both the constitutive proteasome and the immunoproteasome. This efficient proteasomal processing that could be blocked by proteasome inhibitors was highly dependent on the hydrophobic regions flanking the epitope and led to rapid and abundant presentation of the epitope on the cell surface of antigen presenting cells. Our data suggest that rapid antigen processing may be a key immunological feature of this protective and immunodominant HLA-B*27-restricted HCV-specific epitope.Julia SchmidtAstrid K N IversenStefan TenzerEmma GostickDavid A PriceVolker LohmannUte DistlerPaul BownessHansjörg SchildHubert E BlumPaul KlenermanChristoph Neumann-HaefelinRobert ThimmePublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 8, Iss 11, p e1003042 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Julia Schmidt Astrid K N Iversen Stefan Tenzer Emma Gostick David A Price Volker Lohmann Ute Distler Paul Bowness Hansjörg Schild Hubert E Blum Paul Klenerman Christoph Neumann-Haefelin Robert Thimme Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope. |
description |
HLA-B*27 exerts protective effects in hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections. While the immunological and virological features of HLA-B*27-mediated protection are not fully understood, there is growing evidence that the presentation of specific immunodominant HLA-B*27-restricted CD8+ T-cell epitopes contributes to this phenomenon in both infections. Indeed, protection can be linked to single immunodominant CD8+ T-cell epitopes and functional constraints on escape mutations within these epitopes. To better define the immunological mechanisms underlying HLA-B*27-mediated protection in HCV infection, we analyzed the functional avidity, functional profile, antiviral efficacy and naïve precursor frequency of CD8+ T cells targeting the immunodominant HLA-B*27-restricted HCV-specific epitope as well as its antigen processing and presentation. For comparison, HLA-A*02-restricted HCV-specific epitopes were analyzed. The HLA-B*27-restricted CD8+ T-cell epitope was not superior to epitopes restricted by HLA-A*02 when considering the functional avidity, functional profile, antiviral efficacy or naïve precursor frequency. However, the peptide region containing the HLA-B*27-restricted epitope was degraded extremely fast by both the constitutive proteasome and the immunoproteasome. This efficient proteasomal processing that could be blocked by proteasome inhibitors was highly dependent on the hydrophobic regions flanking the epitope and led to rapid and abundant presentation of the epitope on the cell surface of antigen presenting cells. Our data suggest that rapid antigen processing may be a key immunological feature of this protective and immunodominant HLA-B*27-restricted HCV-specific epitope. |
format |
article |
author |
Julia Schmidt Astrid K N Iversen Stefan Tenzer Emma Gostick David A Price Volker Lohmann Ute Distler Paul Bowness Hansjörg Schild Hubert E Blum Paul Klenerman Christoph Neumann-Haefelin Robert Thimme |
author_facet |
Julia Schmidt Astrid K N Iversen Stefan Tenzer Emma Gostick David A Price Volker Lohmann Ute Distler Paul Bowness Hansjörg Schild Hubert E Blum Paul Klenerman Christoph Neumann-Haefelin Robert Thimme |
author_sort |
Julia Schmidt |
title |
Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope. |
title_short |
Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope. |
title_full |
Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope. |
title_fullStr |
Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope. |
title_full_unstemmed |
Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope. |
title_sort |
rapid antigen processing and presentation of a protective and immunodominant hla-b*27-restricted hepatitis c virus-specific cd8+ t-cell epitope. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2012 |
url |
https://doaj.org/article/c948d12be085467aa0d4b5ccb27562d4 |
work_keys_str_mv |
AT juliaschmidt rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT astridkniversen rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT stefantenzer rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT emmagostick rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT davidaprice rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT volkerlohmann rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT utedistler rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT paulbowness rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT hansjorgschild rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT huberteblum rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT paulklenerman rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT christophneumannhaefelin rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope AT robertthimme rapidantigenprocessingandpresentationofaprotectiveandimmunodominanthlab27restrictedhepatitiscvirusspecificcd8tcellepitope |
_version_ |
1718424566971236352 |